ADUS
Price
$125.49Alerts
Change
-$0.80 (-0.63%)
Updated
Nov 11 closing price
Capitalization
2.32B
109 days until earnings call
Intraday BUY SELL Signals
PIII
Price
$2.61Alerts
Change
-$0.77 (-22.78%)
Updated
Nov 11 closing price
Capitalization
15.65M
140 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADUS vs PIII

ADUS vs PIII Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADUS vs. PIII commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a StrongBuy and PIII is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADUS with price predictions
Nov 11, 2026

ADUS in upward trend: 10-day moving average moved above 50-day moving average on October 22, 2026

The 10-day moving average for ADUS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ADUS as a result. In 62 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for ADUS just turned positive on October 08, 2026. Looking at past instances where ADUS's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.

ADUS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 202 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

The Aroon Indicator entered an Uptrend today. In 142 of 218 cases where ADUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for ADUS moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 19 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 64 cases where ADUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

ADUS broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.022) is normal, around the industry mean (204.532). P/E Ratio (21.433) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.483) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for PIII with price predictions
Nov 11, 2026

PIII in +11.26% Uptrend, growing for three consecutive days on November 09, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PIII advanced for three days, in 197 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PIII's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Moving Average Convergence Divergence (MACD) for PIII just turned positive on October 22, 2026. Looking at past instances where PIII's MACD turned positive, the stock continued to rise in 29 of 35 cases over the following month. The odds of a continued upward trend are 83%.

PIII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PIII as a result. In 79 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The 50-day moving average for PIII moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PIII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PIII entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.170) is normal, around the industry mean (204.532). P/E Ratio (-0.121) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. PIII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PIII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADUS: Fundamental Ratings
ADUS
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
72
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADUSPIII
RSI
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
65%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ADUS: $125.49 vs. PIII: $2.61)
Brand notoriety: ADUS and PIII are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ADUS: 99% vs. PIII: 524%
Market capitalization -- ADUS: $2.32B vs. PIII: $15.65M
ADUS [@Hospital/Nursing Management] is valued at $2.32B. PIII’s [@Hospital/Nursing Management] market capitalization is $15.65M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADUS’s FA Score shows that 0 FA rating(s) are green while PIII’s FA Score has 2 green FA rating(s).

  • ADUS’s FA Score: 0 green, 5 red.
  • PIII’s FA Score: 2 green, 3 red.
According to our system of comparison, ADUS is a better buy in the long-term than PIII.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADUS’s TA Score shows that 6 TA indicator(s) are bullish while PIII’s TA Score has 4 bullish TA indicator(s).

  • ADUS’s TA Score: 6 bullish, 4 bearish.
  • PIII’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ADUS is a better buy in the short-term than PIII.

Price Growth

ADUS (@Hospital/Nursing Management) experienced а -1.91% price change this week, while PIII (@Hospital/Nursing Management) price change was -36.34% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.72%. For the same industry, the average monthly price growth was +0.44%, and the average quarterly price growth was +11.06%.

Reported Earning Dates

ADUS is expected to report earnings on Mar 01, 2027.

PIII is expected to report earnings on Apr 01, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-5.72% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ADUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with PNTG. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then PNTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADUS
1D Price
Change %
ADUS100%
-0.63%
PNTG - ADUS
41%
Loosely correlated
+0.16%
HCSG - ADUS
38%
Loosely correlated
-0.36%
NHC - ADUS
36%
Loosely correlated
+0.87%
ENSG - ADUS
34%
Loosely correlated
+0.59%
CON - ADUS
32%
Poorly correlated
+1.83%
More

PIII and

Correlation & Price change

A.I.dvisor tells us that PIII and ADUS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PIII and ADUS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIII
1D Price
Change %
PIII100%
-22.78%
ADUS - PIII
24%
Poorly correlated
-0.63%
SGRY - PIII
23%
Poorly correlated
-0.26%
ENSG - PIII
21%
Poorly correlated
+0.59%
OPCH - PIII
21%
Poorly correlated
+0.16%
HCSG - PIII
21%
Poorly correlated
-0.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SASS24.690.19
+0.78%
M.D. Sass Concentrated Value ETF (SASS)
XMAY37.020.21
+0.56%
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May (XMAY)
RZV145.220.52
+0.36%
Invesco S&P Smallcap 600 Pure Value ETF (RZV)
FIGB41.620.04
+0.10%
Fidelity Investment Grade Bond ETF (FIGB)
WX21.82N/A
N/A
Corgi All World 2x Daily ETF (WX)
Interesting Articles